MICHELLE MUNROE: Open Payments
NPI 1861845240 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,806 in 86 payments from 9 companies in 2025. Trend: 2023 $6,626 · 2024 $17,622 · 2025 $31,806
Speaker / faculty: $16,953Consulting: $8,205Travel & lodging: $4,318Food & beverage: $2,215Education: $115
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $11,275 |
| AstraZeneca Pharmaceuticals LP | 22 | $10,394 |
| Daiichi Sankyo Inc. | 15 | $5,436 |
| Janssen Biotech, Inc. | 6 | $2,514 |
| EMD Serono, Inc. | 8 | $1,688 |
| Merck Sharp & Dohme LLC | 7 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $145 |
| Genmab U.S., Inc. | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
Products named: DATROWAY, ALUNBRIG, IMFINZI, RYBREVANT, KEYTRUDA, OPDIVO, TAGRISSO, Enhertu.
Industry payments across IL — which companies pay providers there.
